Drug Shortage Report for RIVA-ALENDRONATE
| Report ID | 215855 |
| Drug Identification Number | 02270889 |
| Brand name | RIVA-ALENDRONATE |
| Common or Proper name | Riva-Alendronate 70mg |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ALENDRONIC ACID |
| Strength(s) | 70MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 4 |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-01-12 |
| Actual start date | 2024-01-12 |
| Estimated end date | |
| Actual end date | 2024-01-17 |
| Shortage status | Resolved |
| Updated date | 2024-01-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-01-18 | English | Compare |
| v6 | 2024-01-17 | French | Compare |
| v5 | 2024-01-17 | English | Compare |
| v4 | 2024-01-13 | English | Compare |
| v3 | 2024-01-12 | French | Compare |
| v2 | 2024-01-12 | English | Compare |
| v1 | 2024-01-12 | English | Compare |
Showing 1 to 7 of 7